Immunotherapy News
🇺🇸 FDAFDA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–12 of 13 articles
Tempest Therapeutics TPST-2003 CAR-T Shows Promise for Multiple Myeloma at ISCT 2026
AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
ACRP 2026: Immunology Clinical Research Highlights - Day 1
ImmunityBio (IBRX) Faces FDA Warning Letter and Class Action Lawsuit Over Anktiva Claims
Greenwich LifeSciences GLSI-100 Abstract Accepted at ASCO 2026 for Breast Cancer Immunotherapy Trial
Tempest Therapeutics Achieves Manufacturing Milestone for TPST-2003 CAR-T Cancer Treatment
Mabwell 9MW2821 Combination Therapy Data to Be Presented at ASCO 2026 for Urothelial Carcinoma Treatment
AACR 2026: ctDNA, Immunotherapy, and KRAS Target Breakthroughs
Innovent Biologics IBI363 Clinical Data to Be Presented at ASCO 2026 Annual Meeting
AACR 2024: Oncology Research Highlights - Day 1 Roundup
AACR 2026: Myocarditis Risk, KRAS Inhibitors, mRNA Advances
Abogen's ABO2203 mRNA Cancer Therapy Shows Promise in First-in-Human B-Cell Lymphoma Trial at AACR 2026